Determination of compliance with anti-TNF alpha treatment and quality of life in inflammatory bowel disease patients
Akademik Gastroenteroloji Dergisi · 21.04.2026 · 25 (1) · 64-71
DOI: 10.17941/agd.1916039 ↗Kurz gefasst
Fachartikel in der Zeitschrift Akademik Gastroenteroloji Dergisi, online erschienen am 21.04.2026. Verfasst von Elif Sözeri Öztürk und 2 weiteren Autor:innen. Die Arbeit nennt 16 Literaturangaben.
Abstract (Originalsprache)
Backgorund and Aims: This study aims to determine the relationship between compliance with anti-tumor necrosis factor alpha treatment and quality of life in inflammatory bowel patients. Materials and Methods: The study was conducted at Gazi University Gastroenterology Department, Inflammatory Bowel Diseases Outpatient Clinic between 15 November 2023 and 1 March 2024. The study was completed with 123 patients. Study data were collected using the “Patient Information Form”, “Ulcerative Colitis Simple Clinical Colitis Activity Index”, “Harvey Bradshaw Activity Index”, and “Inflammatory Bowel Diseases Quality of Life Scale”, “Anti-Tumor Necrosis Factor Alpha Treatment Compliance Scale”.
Results
The total score the patients received from the Inflammatory Bowel Diseases Quality of Life Scale was 159.40 ± 32.56. The total mean score of the patients on the Anti- Tumor Necrosis Factor Alpha Treatment Compliance Scale was 2.36 ± 0.70. A moderate, negative relationship was found between the mean scores of the patients from the “Personal Factors” sub-dimension of the Anti-Tumor Necrosis Factor Alpha Treatment Compliance Scale and the total and all sub-dimensions of Inflammatory Bowel Diseases Quality of Life Scale (p < 0.001).
Conclusion
A moderate negative relationship was found between total mean scores of “Worrying and Coping” sub-dimension of Anti-Tumor Necrosis Factor Alpha Treatment Compliance Scale and total mean scores of all sub-dimensions of Inflammatory Bowel Diseases Quality of Life Scale (p < 0.001).
Zitieren
APA
Öztürk, E. S., Uçan, Ş., & Karakan, T. (2026). Determination of compliance with anti-TNF alpha treatment and quality of life in inflammatory bowel disease patients. Akademik Gastroenteroloji Dergisi, 25(1), 64-71. https://doi.org/10.17941/agd.1916039
Vancouver
Öztürk ES, Uçan Ş, Karakan T. Determination of compliance with anti-TNF alpha treatment and quality of life in inflammatory bowel disease patients. Akademik Gastroenteroloji Dergisi. 2026;25(1):64-71. doi:10.17941/agd.1916039
BibTeX
@article{ztrk2026,
author = {Öztürk, Elif Sözeri and Uçan, Şenay and Karakan, Tarkan},
title = {Determination of compliance with anti-TNF alpha treatment and quality of life in inflammatory bowel disease patients},
journal = {Akademik Gastroenteroloji Dergisi},
year = {2026},
volume = {25},
number = {1},
pages = {64--71},
doi = {10.17941/agd.1916039}
}
EUVIMED